MCON Rasayan

Q3 FY24 Earnings Call Analysis

Other Construction Materials

Full Stock Analysis
fundraise: Yescapex: Yesrevenue: Category 1margin: Category 1orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- The recent fundraise was around ₹16 crores, primarily for working capital to support rapid growth in the next two quarters and the subsequent financial year. - The fundraise aims to cover increasing turnover, shorter payment cycles in outsourcing, and expansion of product range requiring new raw materials and packaging. - With the current fundraise, the company expects to sustain revenue growth up to around ₹200-₹250 crores. - No explicit mention of any immediate or future new fundraising through debt or equity beyond this. - Fundraising decisions will depend on the speed of growth and government projects, with potential to raise more if growth accelerates beyond current targets.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- MCON Rasayan is expanding manufacturing capacity through multiple FOCO (Franchise Owned Company Operated) and outsourcing models across locations like Faridabad, Solapur, Indore, Pune, Ghaziabad, Bangalore, Bhiwandi, and New Bombay. - Five manufacturing plants are currently operational with another three expected to be operational within 2-3 months, increasing capacity and reducing transportation costs. - FOCO model in Solapur is a strategic move to support Maharashtra Housing Development Corporation (MHDC) projects, enabling localized manufacturing. - Existing plants such as Vapi, Ambethi, and Sarigam have capacity utilization of 67%-87%, with scope to run double or two and a half shifts, enabling potential production capacity of ₹400-500 crore. - Focus on enhancing product mix towards higher-margin specialized products. - Investment in quality control labs at franchise plants like Solapur to ensure consistent quality adherence. - Recent ₹16 crore fundraise primarily aimed at working capital to support rapid growth and expansion.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Targeting 80% to 100% year-on-year revenue growth in the near future. - For FY25, expected turnover around ₹80 crore, with some shortfall in H1 expected to be compensated in H2. - Current market share under 1% in a ₹3,000 crore market, indicating significant growth potential. - Capacity utilization at 70-80% for single shift, with potential to double production with additional shifts. - Changing product mix towards higher margin products like admixtures to improve profitability. - Expansion into new geographies like UP and Karnataka with new distributors onboard. - Government projects, especially under Prime Minister Awas Yojana in Maharashtra, expected to contribute roughly 10-15% of revenue. - Working capital infusion through recent fundraise supports targeted growth. - Manufacturing expansion via outsourcing and additional plants to increase production capacity.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- The company targets 80% to 100% year-on-year revenue growth over the next few years. - FY25 revenue guidance is around ₹80 crore, with potential to achieve ₹150 crore in FY26. - EBITDA margins expected to improve gradually, with single-digit percentage increases year-on-year. - Long-term stable EBITDA margin guidance is between 16% to 20%. - Profit After Tax (PAT) is expected to grow alongside revenue and margin improvements. - Working capital infusion and expanded manufacturing capacity support rapid growth without immediate further fundraises up to ~₹200-250 crore revenue level. - EPS growth expected consistent with robust revenue and margin expansion. - Product mix shifting towards higher-margin admixtures and specialized products will help improve profitability.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The transcript provided does not explicitly mention the current or expected order book or pending orders for MCON Rasayan India Ltd. Specific details on orderbook or pending orders were not discussed during the call based on the available pages. The discussion primarily covered revenues, growth targets, capacity utilization, fundraise, product mix, and competition. If you need detailed figures or updates on orderbook/pending orders, those might be found in other parts of the company's official disclosures or future earnings calls.